Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Pfizer A7471009, A Randomized Double Blind Phase 3 Efficacy and Safety Study of PF-00299804 versus Erlotinib for the Treatment of Advanced Non-Small C


Collapse Overview 
Collapse sponsor award id
PF


Collapse Biography 

Collapse Time 
Collapse start date
2011-11-22